Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors while in the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advances review discovered that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availab... https://annee273xpg9.smblogsites.com/profile